JAK2 and myeloproliferative disorder: Although hypervolemia secondary to hepatic disease and/or hypersplenism might explain the normalization of blood values, the presence of a latent MPN in which a small JAK2-positive clone without additional mutations that has not yet been able to develop an overt MPN would be an alternative explanation.